Free The Official Patient's Sourcebook on Lupus by MD James N. Parker, PH.D Philip M. Parker

of Health that offer additional information on trials:
    · For clinical studies at the Warren Grant Magnuson Clinical Center
    located in Bethesda, Maryland, visit their Web site:
    http://clinicalstudies.info.nih.gov/

    40 Lupus Nephritis
    · For clinical studies conducted at the Bayview Campus in Baltimore,
    Maryland, visit their Web site:
    http://www.jhbmc.jhu.edu/studies/index.html
    · For trials on diseases of the digestive system and kidneys, and diabetes,
    visit the National Institute of Diabetes and Digestive and Kidney
    Diseases: http://www.niddk.nih.gov/patient/patient.htm

    General References

    The following references describe clinical trials and experimental medical
    research. They have been selected to ensure that they are likely to be
    available from your local or online bookseller or university medical library.
    These references are usually written for healthcare professionals, so you may
    consider consulting with a librarian or bookseller who might recommend a
    particular reference. The following includes some of the most readily
    available references (sorted alphabetically by title; hyperlinks provide
    rankings, information and reviews at Amazon.com):
    · A Guide to Patient Recruitment : Today’s Best Practices & Proven
    Strategies by Diana L. Anderson; Paperback - 350 pages (2001), CenterWatch, Inc.; ISBN: 1930624115;
    http://www.amazon.com/exec/obidos/ASIN/1930624115/icongroupinterna
    · A Step-By-Step Guide to Clinical Trials by Marilyn Mulay, R.N., M.S., OCN; Spiral-bound - 143 pages Spiral edition (2001), Jones & Bartlett Pub; ISBN: 0763715697;
    http://www.amazon.com/exec/obidos/ASIN/0763715697/icongroupinterna
    · The CenterWatch Directory of Drugs in Clinical Trials by CenterWatch; Paperback - 656 pages (2000), CenterWatch, Inc.; ISBN: 0967302935;
    http://www.amazon.com/exec/obidos/ASIN/0967302935/icongroupinterna
    · The Complete Guide to Informed Consent in Clinical Trials by Terry
    Hartnett (Editor); Paperback - 164 pages (2000), PharmSource Information
    Services, Inc.; ISBN: 0970153309;
    http://www.amazon.com/exec/obidos/ASIN/0970153309/icongroupinterna
    · Dictionary for Clinical Trials by Simon Day; Paperback - 228 pages (1999), John Wiley & Sons; ISBN: 0471985961;
    http://www.amazon.com/exec/obidos/ASIN/0471985961/icongroupinterna
    · Extending Medicare Reimbursement in Clinical Trials by Institute of
    Medicine Staff (Editor), et al; Paperback 1st edition (2000), National
    Academy Press; ISBN: 0309068886;
    http://www.amazon.com/exec/obidos/ASIN/0309068886/icongroupinterna

    Trials 41
    · Handbook of Clinical Trials by Marcus Flather (Editor); Paperback (2001), Remedica Pub Ltd; ISBN: 1901346293;
    http://www.amazon.com/exec/obidos/ASIN/1901346293/icongroupinterna

    Vocabulary Builder

    The following vocabulary builder gives definitions of words used in this
    chapter that have not been defined in previous chapters:

    Abdomen: That portion of the body that lies between the thorax and the pelvis. [NIH]
    Antibody: An immunoglobulin molecule that has a specific amino acid
    sequence by virtue of which it interacts only with the antigen that induced
    its synthesis in cells of the lymphoid series (especially plasma cells), or with antigen closely related to it. Antibodies are classified according to their ode of action as agglutinins, bacteriolysins, haemolysins, opsonins, precipitins,
    etc. [EU]
    Aspiration: The act of inhaling. [EU]
    Biopsy: The removal and examination, usually microscopic, of tissue from the living body, performed to establish precise diagnosis. [EU]
    Catheter: A tubular, flexible, surgical instrument for withdrawing fluids from (or introducing fluids into) a cavity of the body, especially one for
    introduction into the bladder through the urethra for the withdraw of urine.
    [EU]
    Cyclophosphamide: Precursor of an alkylating nitrogen mustard
    antineoplastic and immunosuppressive agent that must be activated in the
    liver to form the active aldophosphamide. It is used in the treatment